Why Germany is losing its own medicine industry: ophthalmologists and physicians
Germany is suffering from a shortage of ophthalmic specialists and doctors in their own fields, as well as a growing shortage of specialists and physicians in other fields, according to a report published by the German ophthalmia and pediatrics society.
“The country’s health care system has fallen behind other European countries in terms of its ability to provide specialized services and to meet the needs of the population, as we have seen recently in the case of the shortage of primary care doctors,” Ophthalmia CEO Markus Nijmeijer said in a statement.
The situation is particularly dire for ophthalmolgists and physicians, who are often at the leading edge of the field.
“This is why our membership in the German Association of Ophthalmology (BKA) has fallen to just 11.5 percent, the lowest percentage since we started registering in 2014,” Nijmaer said.
He added that there are more than 20,000 doctors, nurses, optometrists and other doctors in Germany, and that their number is on the rise.
It is difficult to provide basic medical services in Germany without doctors, but the country’s lack of specialized medicine is one of the main reasons for the shortage, according Nijmasoer.
Germany has only 4,000 ophthalmmetrists, a fraction of the world’s 1.2 million, according the International Organization for Standardization (ISO).
“This has an effect on quality of care and has a serious impact on the quality of life for all of us in Germany,” Njmaer told the AP.
As a result, he said that the BKA has taken the necessary measures to fill the gap in the number of ocular specialists.
More on the US presidential election: US: Clinton: ‘This is not going to be over for her’ The AP reported that the shortage has forced doctors to travel long distances to perform their jobs.
Many optometrist and ophthalmoscope physicians are leaving Germany for other countries, including the US, where optometrics is a relatively inexpensive profession.
A spokesperson for Bayer AG, the world-wide drugmaker that makes the drug clozapine, told Reuters the company would like to increase its presence in Germany but cannot until the country has sufficient specialists in other areas.
“We are actively looking to grow our presence in the country,” the spokesperson said.